Literature DB >> 18040987

High-throughput mutational screening for beta-thalassemia by single-nucleotide extension.

Silvia Galbiati1, Marcella Chiari, Micol Macellari, Maurizio Ferrari, Laura Cremonesi, Marina Cretich.   

Abstract

In this work a high-throughput method based on the single-nucleotide extension (SNE) reaction and multicolour detection in a DNA sequencer was developed to screen for eight mutations in the human beta-globin gene: IVSI.110, cd39, IVSI.1, IVSI.6, IVSII.745, HbC, HbS and cd6. The method has been validated on a large number of samples for the two most common mutations causing beta-thalassemia in the Mediterranean area (IVSI.110 and cd39). The development of a high-throughput, fast and reliable method to assay beta-thalassemia mutations represents a significant improvement in molecular diagnosis of this disease. The multicolour detection and the use of multiple injections further enhances the throughput of mutational screening by the DNA sequencer and facilitates automated genotyping for routine molecular diagnostics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18040987     DOI: 10.1002/elps.200700181

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  3 in total

1.  Label-free microarray imaging for direct detection of DNA hybridization and single-nucleotide mismatches.

Authors:  Emre Ozkumur; Sunmin Ahn; Ayça Yalçin; Carlos A Lopez; Elif Cevik; Rostem J Irani; Charles DeLisi; Marcella Chiari; M Selim Unlü
Journal:  Biosens Bioelectron       Date:  2010-01-04       Impact factor: 10.618

2.  Molecular Diagnostics of β-Thalassemia.

Authors:  B Atanasovska; G Bozhinovski; L Chakalova; S Kocheva; O Karanfilski; D Plaseska-Karanfiska
Journal:  Balkan J Med Genet       Date:  2012-12       Impact factor: 0.519

3.  Efficient detection of Mediterranean β-thalassemia mutations by multiplex single-nucleotide primer extension.

Authors:  Biljana Atanasovska; Georgi Bozhinovski; Dijana Plaseska-Karanfilska; Lyubomira Chakalova
Journal:  PLoS One       Date:  2012-10-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.